跳至主要内容
临床试验/PACTR202111578379735
PACTR202111578379735已完成3 期

Bile Reflux Gastropathy: Prevalence and Risk Factors after Therapeutic Biliary Interventions: A Retrospective Cohort Study

Zagazig University Hospitals0 个研究点目标入组 288 人开始时间: 2021年11月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
288

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1-refractory epigastric pain and dyspeptic symptoms after therapeutic biliary interventions with
  • 2- history of poor response to prokinetics, mucosa-protective medicines, H2-blockers and/or proton-pump inhibitors (PPI).

排除标准

  • 1- unstable cardiopulmonary, neurologic, or cardiovascular status,
  • 2- other causes of biliary diseases (CBD strictures, and hepatolithiasis),
  • 3- structural abnormalities of the esophagus, stomach, or small intestine,
  • 4- patients who underwent bariatric surgery out of the scope of the study,
  • 5- patients on long-term non-steroidal analgesics, and
  • 6- patients on oral contraceptive drugs.

研究者

发起方
Zagazig University Hospitals

相似试验